Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Medicine and Dentistry

• Analysis 100%
• Hepatitis B 100%
• Global Disease Burden 100%
• Hepatitis B Virus 100%
• Prevalence 70%
• Age 50%
• Death 50%
• Child 40%
• Chronic Hepatitis B 40%
• Disease 30%
• Mortality 30%
• Mortality Rate 30%
• Liver Cirrhosis 30%
• Hepatitis Virus 30%
• Liver Cancer 30%
• Incidence 20%
• Deterioration 20%
• Development 10%
• Therapeutic Procedure 10%
• Hospital 10%
• Global Health 10%
• Injury 10%
• Discharge 10%
• Aging 10%
• Motivation 10%
• Cause of Death 10%
• Indicator 10%
• Retinol 10%
• Disparity 10%
• Seroprevalence 10%
• Cancer Registry 10%
• Hepatitis B Vaccination 10%
• Meta-Regression 10%
• Disability Adjusted Life Years 10%
• Population Growth 10%
• Cirrhosis 10%

INIS

• diseases 100%
• hepatitis 100%
• viruses 58%
• death 37%
• WHO 37%
• children 16%
• cancer 16%
• mortality 12%
• liver 8%
• reduction 8%
• comparative evaluations 8%
• populations 8%
• tools 8%
• foundations 4%
• performance 4%
• hospitals 4%
• risks 4%
• people 4%
• data 4%
• validation 4%
• interventions 4%
• growth 4%
• testing 4%
• modeling 4%
• aging 4%
• injuries 4%
• indicators 4%
• member states 4%
• liver cirrhosis 4%
• sustainable development 4%
• gaussian processes 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Hepatitis B 20%
• Pamicogrel 10%